Company Number: 14549446

Analysis Date: 2025-07-20 14:07 UTC

Financial Health Assessment of YR & LJ LIMITED (as of 31 December 2024)

---

1. Financial Health Score: Grade D

Explanation:
YR & LJ LIMITED exhibits very limited financial activity and minimal asset base. With net assets of only £1 and no reported revenues or profits, the financial "vital signs" indicate a company in the very early or dormant stage of its business lifecycle. Though not in distress, the financial health is fragile, reflecting absence of operational substance or cash flow to support growth or resilience.

---

2. Key Vital Signs

Metric	2024 Value	Interpretation
Net Current Assets	£1	Extremely low; almost no working capital
Total Net Assets	£1	Net worth is negligible, indicating minimal scale
Shareholders' Funds	£1	Equity base very small, minimal capital invested
Cash	Not separately disclosed in 2024 but was £3,800 in 2023	Drastic reduction or no cash in 2024, potential cash flow concerns
Employees	0	No staff employed, indicating no operational activity
Revenue / Profit & Loss Account	Zero	No recorded profits or losses, suggests no trading

• Vital sign analogy: The company’s "financial pulse" is barely detectable, akin to a patient in very early infancy or hibernation — minimal activity, limited resources.

---

3. Diagnosis

• Symptoms Analysis:
  The financial statements reveal almost no financial transactions or operating activity during 2024. Current assets and net assets have fallen from £7,300 in 2023 to £1 in 2024, showing a disappearance of cash or receivables. No employees or profit/loss activity suggest the company is either dormant or just formed without commercial operations.

• Underlying Health Condition:
  YR & LJ LIMITED appears to be in a "pre-operational" or dormant phase. This is common for a newly incorporated company (formed in December 2022) yet to commence trading or generate meaningful revenue. The absence of fixed assets and minimal working capital signals no investment in business infrastructure. There is no indication of financial distress such as liabilities exceeding assets, but the company is not yet "healthy" in terms of sustainable trading.

---

4. Prognosis

• Short-term outlook:
  Without injection of capital, commencement of trading, or acquisition of assets, the company’s financial condition will remain stagnant. The minimal asset base and lack of cash flow imply a fragile position vulnerable to any unforeseen expenses.

• Long-term outlook:
  If business activity begins and revenue grows, the company’s financial health could improve significantly. However, as things stand, the prognosis depends entirely on future operational plans and capital support from shareholders or lenders.

---

5. Recommendations

1. Activate Business Operations:
   Begin trading or commercial activities to generate revenue and establish positive cash flow. This will improve the company's financial "vital signs" and reduce risks associated with dormancy.

2. Capital Infusion:
   Consider increasing shareholder funds or securing financing to build a working capital buffer. Healthy cash flow is essential to cover operating expenses and invest in growth.

3. Financial Monitoring:
   Maintain regular financial reviews and produce management accounts to track cash flow, profitability, and asset/liability positions. Early detection of "symptoms" such as cash shortages will allow timely interventions.

4. Cost Control:
   Since there are currently no employees or assets, keep overheads minimal until sustainable revenue streams are established.

5. Strategic Planning:
   Develop a clear business plan outlining revenue models, target markets, and growth milestones. This will support financial planning and attract potential investors or lenders.

---